Webinar Q&A follow up – exploratory biomarker testing: to qualify or validate the assay?
Afshin Safavi, PhD (Founder and Board Member, BioAgilytix, NC, USA) share his responses to the questions posed by our audience during the live webinar event, “Exploratory biomarker testing: to qualify or validate the assay? The latest scientific and regulatory considerations for biomarker validation”.
Share This